{"id":"https://openalex.org/W1899577508","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.3162","title":"A phase II study of ABR-214936 (anatumomab mafenatox) tumour targeted superantigen (TTS) therapy in patients with advanced adenocarcinoma of the pancreas","display_name":"A phase II study of ABR-214936 (anatumomab mafenatox) tumour targeted superantigen (TTS) therapy in patients with advanced adenocarcinoma of the pancreas","publication_year":2004,"publication_date":"2004-07-15","ids":{"openalex":"https://openalex.org/W1899577508","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.3162","mag":"1899577508"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2004.22.14_suppl.3162","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.3162","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.3162","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112757046","display_name":"N. Connolly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"N. B. Connolly","raw_affiliation_strings":["Christie Hospital, Manchester, United Kingdom; Active Biotech Research, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christie Hospital, Manchester, United Kingdom; Active Biotech Research, Lund, Sweden","institution_ids":["https://openalex.org/I4210131968"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044053285","display_name":"David M Shaw","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D. Shaw","raw_affiliation_strings":["Christie Hospital, Manchester, United Kingdom; Active Biotech Research, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christie Hospital, Manchester, United Kingdom; Active Biotech Research, Lund, Sweden","institution_ids":["https://openalex.org/I4210131968"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073120119","display_name":"Jackie Fenemore","orcid":"https://orcid.org/0000-0001-7874-6927","observed_orcids":["https://orcid.org/0000-0001-7874-6927"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Fenemore","raw_affiliation_strings":["Christie Hospital, Manchester, United Kingdom; Active Biotech Research, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christie Hospital, Manchester, United Kingdom; Active Biotech Research, Lund, Sweden","institution_ids":["https://openalex.org/I4210131968"]}]},{"author_position":"middle","author":{"id":null,"display_name":"C. Garner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C. Garner","raw_affiliation_strings":["Christie Hospital, Manchester, United Kingdom; Active Biotech Research, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christie Hospital, Manchester, United Kingdom; Active Biotech Research, Lund, Sweden","institution_ids":["https://openalex.org/I4210131968"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090474666","display_name":"Suzanne Kilany","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. Kilany","raw_affiliation_strings":["Christie Hospital, Manchester, United Kingdom; Active Biotech Research, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christie Hospital, Manchester, United Kingdom; Active Biotech Research, Lund, Sweden","institution_ids":["https://openalex.org/I4210131968"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008021555","display_name":"Gunnar Hedlund","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G. Hedlund","raw_affiliation_strings":["Christie Hospital, Manchester, United Kingdom; Active Biotech Research, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christie Hospital, Manchester, United Kingdom; Active Biotech Research, Lund, Sweden","institution_ids":["https://openalex.org/I4210131968"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113803683","display_name":"G\u00f6ran Forsberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G. Forsberg","raw_affiliation_strings":["Christie Hospital, Manchester, United Kingdom; Active Biotech Research, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christie Hospital, Manchester, United Kingdom; Active Biotech Research, Lund, Sweden","institution_ids":["https://openalex.org/I4210131968"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082997520","display_name":"Peter L. Stern","orcid":"https://orcid.org/0000-0002-0604-9097","observed_orcids":["https://orcid.org/0000-0002-0604-9097"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P. Stern","raw_affiliation_strings":["Christie Hospital, Manchester, United Kingdom; Active Biotech Research, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christie Hospital, Manchester, United Kingdom; Active Biotech Research, Lund, Sweden","institution_ids":["https://openalex.org/I4210131968"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103456638","display_name":"Robert E. Hawkins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R. E. Hawkins","raw_affiliation_strings":["Christie Hospital, Manchester, United Kingdom; Active Biotech Research, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christie Hospital, Manchester, United Kingdom; Active Biotech Research, Lund, Sweden","institution_ids":["https://openalex.org/I4210131968"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210131968"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"14_suppl","first_page":"3162","last_page":"3162"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.82669997215271,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.82669997215271,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.09040000289678574,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.03840000182390213,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma","display_name":"pancreatic ductal adenocarcinoma","score":0.925000011920929},{"id":"https://openalex.org/keywords/5t4-antigen","display_name":"5T4 antigen","score":0.8209999799728394},{"id":"https://openalex.org/keywords/staphylococcal-enterotoxin-a","display_name":"staphylococcal enterotoxin A","score":0.9610000252723694},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.5989999771118164},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.6449999809265137},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.4779999852180481},{"id":"https://openalex.org/keywords/fever","display_name":"fever","score":0.5180000066757202},{"id":"https://openalex.org/keywords/tumor-response","display_name":"tumor response","score":0.6010000109672546}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9068401455879211},{"id":"https://openalex.org/C36333154","wikidata":"https://www.wikidata.org/wiki/Q772950","display_name":"Superantigen","level":4,"score":0.5118216872215271},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5089778900146484},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.4987144470214844},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4866641163825989},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4859289228916168},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46787238121032715},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4528716802597046},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.44895800948143005},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4391452372074127},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.42641955614089966},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4234708547592163},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3450397849082947},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.34501197934150696},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24721050262451172},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.12143167853355408}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2004.22.14_suppl.3162","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.3162","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.3162","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"doi:10.1200/jco.2004.22.90140.3162","doi":"https://doi.org/10.1200/jco.2004.22.90140.3162","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.90140.3162","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4237184606","https://openalex.org/W2619000184","https://openalex.org/W2170974033","https://openalex.org/W2324515582","https://openalex.org/W2230829804","https://openalex.org/W2024164834","https://openalex.org/W2478717604","https://openalex.org/W2094930163","https://openalex.org/W4400151552","https://openalex.org/W2728725819"],"abstract_inverted_index":{"3162":[0],"Tumour":[1],"Targeted":[2],"Superantigen":[3],"therapy":[4],"is":[5,29,101,109,130,138,145,184,197,268,291],"a":[6,30,35,41,78,149,173,189,209,269],"novel":[7],"form":[8],"of":[9,21,34,53,83,96,148],"cancer":[10],"therapy.":[11],"The":[12],"principle":[13],"involves":[14],"targeting":[15],"the":[16,45,51,94,104,117,136,141,178,181],"superantigen":[17],"with":[18,65,77,111,200,264],"subsequent":[19],"activation":[20],"cytotoxic":[22],"T":[23],"cells":[24],"in":[25,50,274],"tumor":[26,161],"tissue.":[27],"ABR214936":[28,84,267],"recombinant":[31],"fusion":[32],"protein":[33],"mutated":[36],"Staphylococcal":[37],"enterotoxin":[38],"A":[39,127],"and":[40,72,98,122,157,170,240,251,271,287],"Fab":[42],"moiety":[43],"recognising":[44],"oncofetal":[46],"antigen":[47],"5T4":[48],"expressed":[49],"majority":[52],"pancreas":[54,68],"cancers.":[55],"In":[56],"this":[57,275],"open":[58],"non":[59],"controlled":[60],"phase":[61],"II":[62],"study":[63],"pts":[64,220,246,258],"histologically":[66],"confirmed":[67],"adenocarcinoma,":[69],"measurable":[70],"disease":[71],"good":[73],"PS":[74],"are":[75],"treated":[76,110,263],"daily":[79],"3":[80],"hour":[81],"infusion":[82,183],"for":[85,180],"4":[86],"consecutive":[87],"days.":[88],"Pre-formed":[89],"circulating":[90],"anti-SEA":[91,119],"antibodies":[92],"neutralise":[93],"effects":[95,164],"ABR-214936":[97],"so":[99],"dosing":[100],"adapted":[102],"to":[103,124,140,159,186,194,204,277,284,297],"pre-existing":[105],"antibody-titre.":[106],"Each":[107],"patient":[108],"an":[112],"individual":[113],"dose":[114,137,179],"based":[115,236],"on":[116],"pre-treatment":[118],"antibody":[120],"concentration":[121],"adjusted":[123,139],"body":[125],"weight.":[126],"second":[128],"cycle":[129],"given":[131],"4\u20136":[132],"weeks":[133],"later":[134],"when":[135],"new":[142],"titre.":[143],"Evaluation":[144],"by":[146],"means":[147],"pre":[150],"treatment":[151],"CT":[152],"scan":[153],"repeated":[154],"at":[155],"D56":[156,244],"D112":[158,256],"evaluate":[160],"response.":[162],"Side":[163],"include":[165],"pyrexia,":[166],"rigors,":[167],"nausea,":[168],"vomiting,":[169],"hypotension.":[171],"If":[172],"drug-related":[174],"AE":[175,212],"SAE":[176],"occured":[177],"next":[182],"decreased":[185],"75%,":[187],"if":[188],"further":[190],"reaction":[191],"then":[192],"reduced":[193],"50%.":[195],"Treatment":[196],"well":[198,288],"tolerated":[199],"no":[201],"withdrawns":[202],"due":[203],"toxicity.":[205],"Approximately":[206],"26%":[207],"experienced":[208],"drug":[210],"related":[211],"most":[213],"commonly":[214],"grade":[215],"1-":[216],"2":[217,224,257],"pyrexia.":[218],"20":[219],"recruited,":[221],"12":[222],"had":[223,233,247,253,259],"cycles,":[225],"7":[226,249,252],"only":[227],"1,":[228],"1":[229,238,241],"withdrew":[230],"consent.":[231],"18":[232],"received":[234],"gemcitabine":[235,265],"chemotherapy,":[237],"5FU":[239],"RT.":[242],"At":[243,255],"6":[245],"SD,":[248],"PD":[250],"died.":[254],"SD.":[260],"Both":[261],"previously":[262],"chemotherapy.":[266],"promising":[270],"active":[272],"agent":[273],"difficult":[276],"treat":[278],"cancer.":[279],"It":[280],"has":[281],"been":[282],"demonstrated":[283],"be":[285],"safe":[286],"tolerated.":[289],"Follow-up":[290],"ongoing.":[292],"No":[293],"significant":[294],"financial":[295],"relationships":[296],"disclose.":[298]},"counts_by_year":[],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2016-06-24T00:00:00"}